Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound for treating peptic ulcer and preparation method and application thereof

A compound and chemical structural formula technology, applied in the field of medicine, can solve problems such as poor water solubility of fumaric acid vonoprazan

Active Publication Date: 2021-05-18
赛隆药业集团股份有限公司
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In order to solve the problem of poor water solubility of vonoprazan fumarate in the prior art, the present invention studies a new class of compounds with good water solubility

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound for treating peptic ulcer and preparation method and application thereof
  • Compound for treating peptic ulcer and preparation method and application thereof
  • Compound for treating peptic ulcer and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1 Synthesis of 5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrole-3-carbaldehyde (compound IV)

[0030]

[0031] At room temperature, add 30 g of 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde (compound II), 100 ml of acetonitrile (CHCN), 29 g of N,N-diisopropylethyl Amine (DIEA) and 4g of 4-dimethylaminopyridine (DMAP), add 35g of pyridine-3-sulfonyl chloride (compound III) at room temperature, stir and react at room temperature for 30min, after the reaction is complete, add water to quench the reaction, use Adjust the pH to 5 with hydrochloric acid, cool down to room temperature, stir and crystallize, filter, and dry under reduced pressure to obtain compound (IV), which is 44 g of yellow powder with a yield of 84%.

[0032] 1H-NMR (CDCl 3 )δ: 9.90 (1H, s), 8.81 (1H, dd, J = 1.4, 4.8Hz), 8.59 (1H, d, J = 2.2Hz), 8.15 (1H, d, J = 1.8Hz), 7.71 ( 1H,dt,J=1.9,8.2Hz), 7.45(1H,m), 7.37(1H,dd,J=4.9,8.1Hz), 7.16(2H,m), δ7.01(1H,t,J= 8.9Hz), 6.67 (1H,d,J=1.7Hz). ...

Embodiment 2

[0033] Example 2 1-[5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrol-3-yl]-N-propylene glycol methylamine monofumaric acid (compound Ⅰ) synthesis

[0034]

[0035] (1) At room temperature, add 43g of compound (IV) and 200ml of methanol to the reaction flask, add 15g of 3-amino-1,2-propanediol, stir for 0.5h, then add 2g of sodium borohydride in N, N-dimethylacetamide solution, stirred and reacted at room temperature for 0.5h, then added 350ml of water, adjusted the pH to 5 with hydrochloric acid, quenched the reaction, then adjusted the pH to 10 with ammonia water, added 450ml of ethyl acetate for extraction, and the organic phase was extracted with water Wash and concentrate under reduced pressure to obtain the free oily state, which is 1-[5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrol-3-yl]-N-propylene glycol methylamine mono Free state of fumaric acid (compound V);

[0036] (2) Add 200ml of N,N-dimethylacetamide to compound V, stir to dissolve, add 14g of fum...

experiment example 1

[0044] Experimental Example 1 Water Solubility Evaluation

[0045] Sample: the compound shown in formula I and vonoprazan fumarate;

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a compound as shown in a formula V or a salt thereof, and the chemical structural formula of the compound is as shown in the formula V. In the formula V, R is a C1-C6 polyhydroxy group; the salt of the compound is selected from fumaric acid and / or hydrochloride and / or sulfate of the compound shown in the formula V; the water solubility of the compound and the salt thereof provided by the invention is improved so that the compound and the salt thereof show a better treatment effect on medication in emergency circumstances. The compound can be prepared into an injection preparation and the like, and can quickly generate a drug effect by administration in an emergency.

Description

technical field [0001] The invention belongs to the field of medicine, and particularly relates to a compound for treating peptic ulcer, its preparation method and application. Background technique [0002] The proton pump inhibitor vonoprazan fumarate can inhibit the secretion of gastric acid to treat peptic ulcer, and it has been widely used clinically. However, the existing vonoprazan fumarate has the problem of poor solubility in water. Specifically, due to the poor water solubility of vonoprazan fumarate, it cannot be formulated into injections, and it is often formulated into oral solid preparations. Because oral solid preparations generally take several hours to show therapeutic effects, it is not conducive to emergency treatment. Medication, therefore needs improvement. Contents of the invention [0003] In order to solve the problem of poor water solubility of vonoprazan fumarate in the prior art, the present invention studies a new class of compounds with good ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/12A61P1/00A61K31/4439A61K9/08
CPCC07D401/12A61P1/00A61K9/0019A61K9/08
Inventor 蔡南桂
Owner 赛隆药业集团股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products